No Data
No Data
Toho Biotech: Report for the third quarter of 2024
baotou dongbao bio-tech (300239.SZ) shareholder Baina Shengyuan collectively reduced their shareholding by 1.14%.
baotou dongbao bio-tech (300239.SZ) announced in a statement that shareholder Hainan Bainashengyuan Technology Co., Ltd. (referred to as "Bainasheng...
Further Upside For Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Shares Could Introduce Price Risks After 37% Bounce
There's Been No Shortage Of Growth Recently For Baotou Dongbao Bio-TechLtd's (SZSE:300239) Returns On Capital
Qingdao Gon Technology (002768.SZ): The holding subsidiary Baotou Dongbao Bio-Tech intends to acquire the remaining shares of Yiqing Bio-Tech
On September 11th, Guo En shares (002768.SZ) announced that Baotou Dongbao Bio-tech Co., Ltd. (referred to as "Dongbao Bio-tech") and Qingdao Yiqing Bio-technology Co., Ltd. (referred to as "Yiqing Bio-tech") are both companies within the scope of the consolidated financial statements of Qingdao Guoen Technology Co., Ltd. Dongbao Bio-tech holds 60% of the shares of Yiqing Bio-tech. In order to further integrate the company's health sector resources, leverage the business synergy of the gelatin industry chain, and improve operational and management efficiency, Dongbao Bio-tech plans to acquire the remaining shares of Yiqing Bio-tech held by minority shareholders. Dongbao Bio-tech has respectively reached agreements with the company and Qingdao Deyu.
Baotou Dongbao Bio-Tech (300239.SZ) plans to acquire the remaining shares of Yi Qing Bio-Tech for 0.232 billion yuan to improve operational management efficiency.
Baotou Dongbao Bio-Tech (300239.SZ) announced that the company currently holds 60% of the shares of Yiqing Bio, and the company plans to acquire the minority...
No Data
No Data